Literature DB >> 8848540

Comparison of measured and FTC-predicted nicotine uptake in smokers.

G D Byrd1, J H Robinson, W S Caldwell, J D deBethizy.   

Abstract

Cigarette smokers have a wide variety of "tar" and nicotine yields to choose from in the current market, ranging from 0.5 mg "tar" and less than 0.05 mg nicotine to 27 mg "tar" and 1.8 mg nicotine by the Federal Trade Commission (FTC) method. To understand better the relationship between FTC nicotine yields and actual nicotine uptake in smokers, we have studied nicotine uptake in 33 smokers of self-selected products representing four "tar" groupings: 1 mg "tar" (1MG), ultra-low "tar" (ULT), full-flavor low "tar" (FFLT), and full flavor (FF) cigarettes. These cigarette categories had mean FTC nicotine yields of 0.14, 0.49, 0.67, and 1.13 mg/cigarette, respectively. The subjects smoked their usual brand of cigarette ad libitum and provided a 24-h urine sample for total nicotine uptake analysis over a period during which the number of cigarettes smoked was recorded. Nicotine uptake was determined by monitoring urinary nicotine and its metabolites, including the glucuronide conjugates. Daily nicotine uptake was 9.1 +/- 7.3 mg (range 1-21 mg) for 1MG, 19.2 +/- 10.0 mg (range 4-42 mg) for ULT, 21.8 +/- 9.4 mg (range 13-38 mg) for FFLT, and 37.1 +/- 14.4 mg (range 21-60 mg) for FF smokers. On a per cigarette basis, yields were 0.23 +/- 0.11, 0.56 +/- 0.23, 0.60 +/- 0.18, and 1.19 +/- 0.43 mg nicotine, respectively. Although individual variability was fairly large (CVs of 0.39-0.80), means for the different groups showed that lower FTC yield smokers not only absorb less nicotine per 24-h period, but also per cigarette smoked. These data suggest that nicotine uptake is a function of individual smoking behavior within product design limits. We conclude from these data that, while FTC yield cannot precisely predict nicotine uptake for an individual smoker, it is useful in predicting and comparing actual nicotine uptake by smokers who select cigarettes with a particular FTC yield.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8848540     DOI: 10.1007/bf02246082

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers.

Authors:  G D Byrd; K M Chang; J M Greene; J D deBethizy
Journal:  Drug Metab Dispos       Date:  1992 Mar-Apr       Impact factor: 3.922

2.  Puffing topography as a determinant of smoke exposure.

Authors:  R B Bridges; J G Combs; J W Humble; J A Turbek; S R Rehm; N J Haley
Journal:  Pharmacol Biochem Behav       Date:  1990-09       Impact factor: 3.533

3.  Stable isotope studies of nicotine kinetics and bioavailability.

Authors:  N L Benowitz; P Jacob; C Denaro; R Jenkins
Journal:  Clin Pharmacol Ther       Date:  1991-03       Impact factor: 6.875

4.  Characterization of the glucuronide conjugate of cotinine: a previously unidentified major metabolite of nicotine in smokers' urine.

Authors:  W S Caldwell; J M Greene; G D Byrd; K M Chang; M S Uhrig; J D deBethizy; P A Crooks; B S Bhatti; R M Riggs
Journal:  Chem Res Toxicol       Date:  1992 Mar-Apr       Impact factor: 3.739

5.  Cigarette yields of tar and nicotine and markers of exposure to tobacco smoke.

Authors:  D B Coultas; C A Stidley; J M Samet
Journal:  Am Rev Respir Dis       Date:  1993-08

6.  Direct determination of cotinine-N-glucuronide in urine using thermospray liquid chromatography/mass spectrometry.

Authors:  G D Byrd; M S Uhrig; J D deBethizy; W S Caldwell; P A Crooks; A Ravard; R m Riggs
Journal:  Biol Mass Spectrom       Date:  1994-02

Review 7.  Cigarette smoking pharmacokinetics and its relationship to smoking behaviour.

Authors:  T D Darby; J E McNamee; J M van Rossum
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

8.  Self-titration by cigarette smokers.

Authors:  H Ashton; R Stepney; J W Thompson
Journal:  Br Med J       Date:  1979-08-11

9.  Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine.

Authors:  N L Benowitz; P Jacob; I Fong; S Gupta
Journal:  J Pharmacol Exp Ther       Date:  1994-01       Impact factor: 4.030

10.  Nicotine pharmacokinetics and its application to intake from smoking.

Authors:  C Feyerabend; R M Ings; M A Russel
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

View more
  8 in total

Review 1.  Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents.

Authors:  L T Kozlowski; R J O'Connor
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

2.  UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.

Authors:  Jeannette Zinggeler Berg; Linda B von Weymarn; Elizabeth A Thompson; Katherine M Wickham; Natalie A Weisensel; Dorothy K Hatsukami; Sharon E Murphy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

Review 3.  Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

Authors:  Min-Ae Song; Neal L Benowitz; Micah Berman; Theodore M Brasky; K Michael Cummings; Dorothy K Hatsukami; Catalin Marian; Richard O'Connor; Vaughan W Rees; Casper Woroszylo; Peter G Shields
Journal:  J Natl Cancer Inst       Date:  2017-12-01       Impact factor: 13.506

4.  Whose standard is it, anyway? How the tobacco industry determines the International Organization for Standardization (ISO) standards for tobacco and tobacco products.

Authors:  S A Bialous; D Yach
Journal:  Tob Control       Date:  2001-06       Impact factor: 7.552

5.  Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats.

Authors:  Andrew C Harris; Christina Mattson; Mark G Lesage; Daniel E Keyler; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2010-05-18       Impact factor: 3.533

Review 6.  Methods used in internal industry clinical trials to assess tobacco risk reduction.

Authors:  Vaughan W Rees; Jennifer M Kreslake; Richard J O'Connor; K Michael Cummings; Mark Parascandola; Dorothy Hatsukami; Peter G Shields; Gregory N Connolly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

7.  A High Throughput Method for Estimating Mouth-Level Intake of Mainstream Cigarette Smoke.

Authors:  Xizheng Yan; Liqin Zhang; Bryan A Hearn; Liza Valentín-Blasini; Gregory M Polzin; Clifford H Watson
Journal:  Nicotine Tob Res       Date:  2015-02-02       Impact factor: 4.244

8.  Using Monte Carlo simulation to assess variability and uncertainty of tobacco consumption in a city by sewage epidemiology.

Authors:  De-Gao Wang; Qian-Qian Dong; Juan Du; Shuo Yang; Yun-Jie Zhang; Guang-Shui Na; Stuart G Ferguson; Zhuang Wang; Tong Zheng
Journal:  BMJ Open       Date:  2016-02-17       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.